Loading…
Sunday, June 24 • 1:00pm - 4:30pm
#36: Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Tutorial
CE: ACPE 3.25 Knowledge UAN: 0286-0000-18-512-L04-P; CME 3.25; IACET 3.25; RN 3.25

In a post Sovaldi world, payers and industry are regularly at loggerheads on price. Payers complain that their budgets are being decimated, whilst industry states that therapies are now more effective and deserve higher prices. Patients, often, are being caught in the middle. This short course will show that the seemingly intractable pricing impasse is driven by our current system of evaluating new treatments based only on 6-9 months of mean response in a clinical trial, with success determined by a statistical 'p-value'. It will highlight examples of how RWE can be better used to facilitate earlier access, measure outcomes, address value long term across the entire health system, and offer more creative pricing solutions to facilitate better patient access. In addition, this short course will address the Pricing, Value, and Access challenges being caused by highly effective targeted therapies such as IO Checkpoint, CAR T, and Gene Therapies. The short course will feature:
  • Pricing and value case-studies based on current clinical therapies such as CAR T, IO checkpoint, and HEP C
  • Interactive workshop discussions on various payment options such as annuity, up front, or pay on performance
  • An overview of the Italian outcomes system of reimbursement and how it has impacted price and access
  • Real-time cost and outcomes modeling to test and aid discussions on various options to stakeholders
  • Horizon scanning discussions on the impact of cures in areas such as Duchene Muscular Dystrophy, Viral Therapies, or Alzheimer’s which may arrive in 3 5 years: How can we plan now? What should we do differently?
An additional registration fee is required for all preconference short courses. Back to DIA 2018 Short Courses  

Who should attend?

This short course is designed for Regulators, Insurance (Payers) both National and Private, HTAs, Industry Access Managers (both Large Pharma and Biotech), Health IT Providers, VCs and Fund managers, Patient Advocates.

Learning Objectives

At the conclusion of this course, participants should be able to:
  • Compare short and long term outcomes and their impacts on budgets
  • Discuss and evaluate different pricing scenarios in group settings
  • Demonstrate use cases for RWE in pricing and reimbursemen



Speakers
avatar for Amr Makady

Amr Makady

Pharmacoeconomics Advisor, Zorginstituut Nederland
Amr is a pharmacist by training, having completed his PharmD degree in Egypt before moving to the Netherlands to pursue his Master’s studies at Utrecht University in the field of pharmaceutical policy. Recently, Amr completed his PhD degree at Utrecht University whereby his thesis... Read More →
avatar for Luca Pani

Luca Pani

Former, AIFA; Professor, Department of Psychiatry and Behavioral Sciences, University of Miami
Luca Pani is Professor of Clinical Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Miami, and Executive Director for Global Medical Innovation, NeuroCog Trials, USA. As former Director General of the Italian Medicines Agency (AIFA) and member of the CHMP... Read More →
avatar for Julian Raffoul

Julian Raffoul

Clinical Scientist, Nashville Biosciences
Dr. Raffoul is an Internal Medicine trained M.D./Ph.D. from Wayne State University who has studied the molecular effects of DNA repair deficiencies on aging and cancer phenotypes, completing a fellowship in molecular therapeutics at the Karmanos Cancer Institute. He also completed... Read More →
avatar for Brian Rothman

Brian Rothman

Senior Director, Office of the Chief Hospital Information Officer, Vanderbilt University Medical Center
Brian Rothman, MD, is Associate Professor of Anesthesiology and Medical Director of Perioperative Informatics at Vanderbilt University Medical Center. He received his medical degree from the University of Cincinnati and completed his residency at The Johns Hopkins Hospital. He is... Read More →
avatar for Duane Schulthess

Duane Schulthess

Managing Director, Vital Transformation
Duane is the Managing Director of Vital Transformation which consults to national health authorities, blue chip multi-national organisations, governments, and stakeholder groups on healthcare policy and technology. He and his firm have developed many unique techniques and methods... Read More →


Sunday June 24, 2018 1:00pm - 4:30pm
Room 162B Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA